Search Results for: International Stem Cell Corporation to
Articles
Chiesi & Protalix Announce Phase 3 Data From BRIGHT Study in Fabry Disease March 18, 2022
Protalix BioTherapeutics, Inc. and Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., recently announced final results from the BRIGHT Phase 3 clinical trial evaluating pegunigalsidase alfa….
PDS Biotech Announces Clinical Trial With Mayo Clinic to Study PDS0101 in Early Stage Pre-Metastatic- HPV-Associated Head & Neck Cancer February 15, 2022
PDS Biotechnology Corporation recently announced the initiation of an Investigator-Initiated Trial (ITT), MC200710, for PDS0101 alone or in combination with the...Dyadic & Phibro Animal Health Announce Exclusive License Agreement to Develop & Commercialize Animal Health Vaccine February 10, 2022
Dyadic International, Inc. and Phibro Animal Health recently announced they have entered into an exclusive license agreement for a Phibro...PDS Biotech Granted Patent for its Novel HPV16 Immunotherapy January 10, 2022
PDS Biotechnology Corporation recently announced it has been granted US Patent Application No. 15,724,818 titled Novel HPV16 Non HLA-Restricted T-cell...Sosei Heptares & Verily to Collaborate to Generate Novel Drug Candidates Against GPCR Targets for Immune-Mediated Diseases January 6, 2022
Sosei Group Corporation and Verily recently announced they have entered into a strategic research collaboration. The research agreement brings together the….
INHALATION THERAPY - An Overview to Drug-Nebulizer Combination Development With Biologics November 30, 2021
Hernan Cuevas Brun, MBA, says biologic drugs are increasingly being investigated for delivery with inhalation therapy, which has initiated more in-depth discussions about the implications of formulation development and their pairing with adequate inhaled devices for more efficient treatment outcomes.
CN Bio & iiCON Announce COVID-19 Research Collaboration November 9, 2021
CN Bio recently announced a research collaboration with the Infection Innovation Consortium (iiCON), a global collaborative infectious disease R&D program,...Adaptive Biotechnologies Launches Enhanced clonoSEQ Assay Reports for Patients With Chronic Lymphocytic Leukemia, Now Featuring IGHV Mutation Status October 5, 2021
Adaptive Biotechnologies Corporation recently announced the launch of an enhanced version of its clonoSEQ B-cell Clonality (ID) report, which will...The FDA Expands Collaboration With CN Bio to Investigate Lung-on-a-Chip Model for Inhaled Drug Evaluation Applications May 6, 2021
CN Bio recently announced the US FDA has extended its research collaboration for an additional 3 years. The scope of...Micropore Appoints Technology Distributor for Japanese Market March 17, 2021
Award-winning UK-based particle engineering specialist Micropore Technologies has just announced the appointment of the Mutual Corporation as the representative for sales….
Passage Bio Teams With Catalent to Start cGMP Manufacturing for Lead Gene Therapy Products December 9, 2020
Passage Bio, Inc. and Catalent recently announced that manufacturing operations have commenced to support adeno-associated virus (AAV) production for Passage Bio’s lead….
Proveris Scientific Research Collaboration: New Generation Technologies for Improved Measurement of Pharmaceutical Aerosols October 7, 2020
Proveris Scientific Corporation recently announced its research collaboration with The University of Sydney and Macquarie University on a project to develop a new generation of technologies for improving….
Protalix BioTherapeutics & Chiesi Global Rare Diseases Announce US FDA Acceptance of Biologics License Application August 12, 2020
Protalix BioTherapeutics, Inc. together with its development and commercialization partner Chiesi Global Rare Diseases recently announced the US FDA has accepted the Biologics License Application (BLA) and granted….
Bioasis & Chiesi Group Announce Rare Diseases Strategic Alliance June 29, 2020
Bioasis Technologies, Inc. and Chiesi Global Rare Diseases recently announced they have entered into a worldwide, exclusive licensing agreement for the….
FORMULATION DEVELOPMENT - Formulating Immediate-Release Tablets for Poorly Soluble Drugs June 4, 2020
Gayatri Khanvilkar, MPharm, Ajit Bhagat, Sangmesh Torne, PhD, Tejas Gunjikar, PhD, and Amina Faham, PhD, present a case study showing that previously unviable APIs can be successfully processed with the right methods, which should give hope to formulators facing similar difficulties.
CURE Pharmaceutical Expands Distribution of CUREfilm Technology With First Licensing Agreement September 5, 2018
CURE Pharmaceutical recently announced it entered into a multi-year licensing agreement for the first time with a leading international cannabis company.
SPECIAL FEATURE - Outsourcing Formulation Development & Manufacturing: CDMOs Are Innovating for 21st-Century Medicine June 6, 2018
Contributor Cindy H. Dubin speaks with some of the industry’s leading CDMOs about the innovations they are developing for next-generation patient care, and how many are making investments that are enabling them to offer more services under one roof.
EPR SPECTROSCOPY - Bringing EPR to a Wider World: Biological ROS & RNS Detection April 2, 2018
Kalina Ranguelova, PhD, demonstrates how the latest digital and microwave technologies in benchtop EPR instrumentation is giving researchers new insight into ROS and free radicals that may shape the future development of more effective treatments of disease.
PARTICLE DESIGN TECHNOLOGY - Technical Guide for Solid Dispersion Development January 9, 2018
Nathan Barksdale and Elizabeth Hickman, MBA, say there are many articles on the theory and scientific principles underpinning the benefits of ASD, and introduce the reader to the steps involved in the development and manufacturing of an ASD via the spray drying process.
Immunovaccine & Leidos Expand Collaboration November 27, 2017
Immunovaccine Inc. recently announced it is expanding its collaboration with Leidos to develop preventative, peptide-based malaria vaccine candidates. The US...
